Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Danaher Corporation (DHR) vs ProShares Ultra Semiconductors (USD) Price & Performance

Danaher CorporationTrade
ProShares Ultra SemiconductorsTrade

Price performance (Past 24H)

Key statistics

Danaher Corporation vs ProShares Ultra Semiconductors — how do they compare? Danaher Corporation trades at $217.88 (market cap $152.87B), while ProShares Ultra Semiconductors trades at $99.48 (market cap $2.94B). The key difference: Danaher Corporation is far larger — about 52× ProShares Ultra Semiconductors's market cap, and Danaher Corporation pays a 0.74% dividend while ProShares Ultra Semiconductors pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and ProShares Ultra Semiconductors for 29 Days on average.

DHRUSD
Market Cap
$152.87B$2.94B
Volume
5,228,698630,148
Sector
HealthLeveraged / Inverse
52-Week High
$242.05$113.53
52-Week Low
$161.91$43.19
Typical Hold Time
69 Days29 Days
Enterprise Value
$175.08B—
Dividend Yield
0.74%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Danaher Corporation

Danaher (DHR) trades at $217.46, up 0.88% on the day, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $24.57B in 2025, though net margins have compressed from historical highs. A quarterly dividend of $0.40 was declared, payable in October 2026.

The outlook remains positive given earnings momentum and institutional accumulation, but valuation multiples are elevated. Risks include margin pressure and high capital expenditure in 2026. The consensus price target of $230.31 implies modest upside, supported by 70% buy ratings from analysts.

ProShares Ultra Semiconductors

USD stock trades at $102.77, down 0.96% on the day, with a bullish technical outlook supported by moving averages. The stock shows strong momentum indicators with ADX signaling trend strength, though RSI levels suggest potential overbought conditions. Recent corporate action includes a $0.13 dividend scheduled for September 2026. Support levels are established at $100-$102, with resistance at $103-$105.

The stock's technical strength contrasts with limited fundamental data availability. Investment opportunity lies in the bullish technical setup and dividend yield, while risks include potential overbought conditions and lack of current financial metrics. Investors should await updated financial reports for fundamental validation of the current price level.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DHR
18% Buy82% Sell
Avg holding period · 69 Days
USD
78% Buy22% Sell
Avg holding period · 29 Days

Top news

Latest headlines on both assets

About Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.

Read more on DHR →

About ProShares Ultra Semiconductors

USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.

Read more on USD →